• Category: Products
Eyedaptic launches latest version of AI-based smart glasses for AMD
Products

Eyedaptic launches latest version of AI-based smart glasses for AMD

Designed for patients with retinal diseases, the EYE7 is an integrated wearable solution with real-time vision enhancements and a new visual assistant.
VirtuaLens launches monovision simulation for VR IOL simulator
Products

VirtuaLens launches monovision simulation for VR IOL simulator

Immersive virtual reality IOL patient education system allows patients to “try on” lens options in a virtual setting ahead of cataract surgery.
Glaukos' Epioxa now commercially available in the US
Products

Glaukos' Epioxa now commercially available in the US

Corneal CXL therapy was approved as the first topical drug therapy not requiring removal of the corneal epithelium for keratoconus treatment.
Heru debuts PretestPro for its wearable VR-based testing platform
Products

Heru debuts PretestPro for its wearable VR-based testing platform

New addition enables full-stack pretesting in under 2 minutes via the company’s signature artificial intelligence and virtual reality-based wearable technology.
FDA approves J&J's TECNIS PureSee IOL for cataract patients
Products

FDA approves J&J's TECNIS PureSee IOL for cataract patients

Approval is the first extended-depth-of-focus lens with no warning on loss of contrast sensitivity; availability to follow later this year.
Hilco Vision launches Ndemex Revitalizing Eye Serum
Products

Hilco Vision launches Ndemex Revitalizing Eye Serum

Latest Bruder product, part of a daily eyelid and lash care routine, is formulated with encapsulated tea tree oil and uses a patented NLP nanotechnology.
FDA tentatively approves Gland Pharma's brimonidine tartrate 0.025% generic
Products

FDA tentatively approves Gland Pharma's brimonidine tartrate 0.025% generic

Final approval and U.S. market launch are still pending for the generic version of Bausch + Lomb’s over-the-counter LUMIFY redness reliever drops.
FDA clears Harrow's IND to initiate phase 3 trial on TRIESENCE
Products

FDA clears Harrow's IND to initiate phase 3 trial on TRIESENCE

Study to kick off in Q1 2026, supporting expansion of corticosteroid’s on-label usage for postop inflammation and pain among all cataract surgery patients.
Rayner acquires Anikavisc ophthalmic viscosurgical device
Products

Rayner acquires Anikavisc ophthalmic viscosurgical device

Formulated with highly purified sodium hyaluronate, the FDA-cleared medical device is designed for use during ophthalmic surgical procedures.
FGH Science launches LidRevive Pro Lash and Eyelid Shampoo for ocular surface health
Products

FGH Science launches LidRevive Pro Lash and Eyelid Shampoo for ocular surface health

Cleanser’s pH-balanced formulation features 15+ amino acids to lift away oils, residue, and support daily use for healthy skin and lashes.
TearRestore launches OneDrop for daily dry eye care
Products

TearRestore launches OneDrop for daily dry eye care

Artificial tear is formulated with a preservative-free-based nanoemulsion engineered to mimic and reinforce all three layers of the natural tear film.
Harrow unveils new direct-to-prescriber cash-pay program for branded products
Products

Harrow unveils new direct-to-prescriber cash-pay program for branded products

Initial rollout of the PharmaPack kits includes FDA-approved NEVANAC, MAXITROL, or TOBRADEX ST for ImprimisRx customers in five states.
FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs
Products

FDA approves expanded age indication for STAAR's EVO/EVO+ Visian ICLs

U.S. age indication now includes patients aged 21 to 60 years old, making nearly 8 million refractive patients eligible for implantable collamer lens implantation.
Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens
Products

Alcon launches TOTAL30 Multifocal for Astigmatism toric contact lens

Designed for astigmatic presbyopes, the latest TOTAL30 is the only monthly MF toric lens featuring proprietary Water Gradient Technology.
FDA approves DifGen's fluorometholone 0.1% complex generic for ocular inflammation
Products

FDA approves DifGen's fluorometholone 0.1% complex generic for ocular inflammation

Prescription-based corticosteroid suspension is the second generic of AbbVie’s FML 0.1% to receive regulatory approval.
BVI reports first US implantations of FINEVISION HP Trifocal IOL
Products

BVI reports first US implantations of FINEVISION HP Trifocal IOL

Surgeon-led rollout includes five successful procedures across the country of the FDA-approved, presbyopia-correcting lens.
AEYE Health broadens Epic EMR integration for AI eye screening
Products

AEYE Health broadens Epic EMR integration for AI eye screening

Expanded deployment enables HCPs to order AEYE-DS’s portable, 1-minute diabetic retinopathy screenings without clinical workflow disruptions. 
Rayner launches AI-based ophthalmic patient education platform
Products

Rayner launches AI-based ophthalmic patient education platform

Mobile app enables clinics to manage, simplify, customize, and integrate surgical patients’ pre- and post-op surgical care via one digital system.
Automated vision-testing kiosks face concerns amid national expansion
Products

Automated vision-testing kiosks face concerns amid national expansion

With Eyebot’s 90-second vision tests rolling out across the country, the AOA is voicing words of caution over the self-administered kiosks.
FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop
Products

FDA approves Tenpoint's YUVEZZI as first dual-agent presbyopia drop

First and only combination drop of carbachol and brimonidine tartrate achieves miosis within 30 minutes and lasts up to 10 hours following once-daily dosing.